drugset / Trial / NCT00309075

Magnevist® Injection Enhanced MRA Compared to Non Contrast MRA for the Detection of Stenosis in the Calf and/or Pedal Arteries

NCT00309075

Phase 3 Completed 126 enrolled Bayer
Non-randomizedSingle-groupOpen-labelDiagnostic

Summary

The purpose of this study is to look at the safety (what are the side effects) and efficacy (how well does it work) of Magnevist (the study drug) used for MRI of the calf and foot arteries. The results will be compared to the results of MRI taken without Magnevist, and with the results of your X-ray angiography.

Timeline

Start
2003-12
Primary completion
Completion
2004-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Gadopentetate dimeglumine Diagnostic / imaging agent 0.1 unknown Intravenous

Indications

No indication recorded.